Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells

Biochemical Pharmacology

Volumn 59, Issue 9, 2000, Pages 1033-1043

  Garay, Michelle ^a   Gaarde, William ^b   Monia, Brett P ^b   Nero, Pamela ^b   Cioffi, Catherine L ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

Apoptosis; c Jun N terminal kinase (JNK); Hypoxia; p38 MAP kinase; Reoxygenation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA FRAGMENT; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; WESTERN BLOTTING;

APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL HYPOXIA; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; OLIGONUCLEOTIDES, ANTISENSE; OXYGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0033963012     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00412-8     Document Type: Article

References (43)

1. Leist M., Nicotera P. The shape of cell death. Biochem Biophys Res Commun. 236:1997;1-9.
2. Schumer M., Colombel M.C., Sawczuk I.S., Gobe G., Connor J., O'Toole K.M., Olssen C.A., Wise G.J., Buttyan R. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol. 140:1992;831-838.
3. Umansky S.R., Cuenco G.M., Khutzian S.S., Barr P.J., Tomei L.D. Post-ischemic apoptotic death of rat neonatal cardiomyocytes. Cell Death Differ. 2:1995;235-241.
4. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
5. Yin T., Sandhu G., Wolfgang C.D., Burrier A., Webb R.L., Rigel D.F., Hai T., Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 32:1997;19943-19950.
6. Savill J. Apoptosis and renal injury. Curr Opin Nephrol Hypertens. 4:1995;263-269.
7. Haunstetter A., Izumo S. Basic mechanisms and implications for cardiovascular disease. Circ Res. 82:1998;1111-1129.
8. Seko Y., Tobe K., Ueki K., Kadowaki T., Yazaki Y. Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases and S6 kinase in cultured rat cardiac myocytes. Circ Res. 78:1996;82-90.
9. Ouellette A.J., Malt R.A., Sukhatme V.P., Bonventre J.V. Expression of two "immediate-early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest. 85:1990;766-771.
10. McCord J.M. Oxygen-derived radicals A link between reperfusion injury and inflammation . Fedn Proc. 46:1987;2402-2406.
11. Werns S.W., Lucchesi B.R. Free radicals and ischemic tissue injury. Trends Pharmacol Sci. 11:1990;161-166.
12. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
13. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
14. Bogoyevitch M.A., Gillespie-Brown J., Ketterman A.J., Fuller S.J., Ben-Levy R., Ashworth A., Marshall C.J., Sugden P.H. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK Mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 79:1996;162-173.
15. Yue T.-L., Ma X.-L., Wang X., Romanic A.M., Liu G-l, Louden C., Gu J.-L., Kumar S., Poste G., Ruffolo R.R. Jr, Feuerstein G.Z. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res. 82:1998;166-174.
16. Pombo C.M., Bonventre J.V., Avruch J., Woodgett J.R., Kyriakis J.M., Force T. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem. 42:1994;26546-26551.
17. Onishi I., Tani T., Hashimoto T., Shimizy K., Yagi M., Yamamoto K., Yoshioka K. Activation of c-Jun N-terminal kinase during ischemia and reperfusion in mouse liver. FEBS Lett. 420:1997;201-204.
18. PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun. 239:1997;840-844.
19. Laderoute K.R., Webster K.A. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res. 80:1997;336-344.
20. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
21. Cavigelli M., Dolfi F., Claret F.-X., Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:1995;5957-5964.
22. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 268:1993;14553-14556.
23. Cobb M.J., Goldsmith E.J. How MAP kinases are regulated. J Biol Chem. 270:1995;14843-14846.
24. Cano E., Hazzalin C.A., Mahadevan L.C. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol. 14:1994;7352-7362.
25. Zanke B.W., Boudreau K., Rubie E., Winnett E., Tibbles L.A., Zon L., Kyriakis J., Liu F.-F., Woodgett J.R. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol. 6:1996;606-613.
26. Woodgett J.R., Kyriakis J.M., Avruch J., Zon L.I. Reconstitution of novel signalling cascades responding to cellular stress. Philos Trans R Soc Lond Biol Sci. 351:1996;135-142.
27. Whitmarsh A.J., Yang S.-H., Su M.S.S., Sharrocks A.D., Davis R.J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol. 17:1997;2360-2371.
28. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
29. 2-terminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine. J Biol Chem. 272:1997;18261-18266.
30. Monia B.P., Johnston J.F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med. 2:1996;668-675.
31. Altmann K.-H., Fabbro D., Dean N.M., Geiger T., Monia B.P., Muller M., Nicklin P. Second-generation antisense oligonucleotides Structure-activity relationships and the design of improved signal-transduction inhibitors . Biochem Soc Trans. 24:1996;630-636.
32. McGahon A.J., Martin S.J., Bissonnette R.P., Mahboubi A., Shi Y., Mogil R.J., Nishioka W.K., Green D.R. The end of the (cell) line Methods for the study of apoptosis in vitro . Schwartz L.M., Osborne B.A. Cell Death. 1995;153-185 Academic Press, San Diego, CA.
33. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
34. 2-terminal kinase-mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J Biol Chem. 272:1997;4631-4636.
35. Bost F., McKay R., Dean N., Mercola D. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J Biol Chem. 272:1997;33422-33429.
36. Reimer K.A., Jennings R.B. Myocardial ischemia, hypoxia and infarction. Fozzard H.A. The Heart and Cardiovascular System. 1986;1133-1159 Raven Press, New York.
37. Chen Y.-R., Wang X., Templeton D., Davis R.J., Tan T.-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem. 271:1996;31929-31936.
38. Luo Y., Umegaki H., Wang X., Abe R., Roth G.S. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem. 273:1998;3756-3764.
39. Meriin A.B., Gabai V.L., Yaglom J., Shifrin V.I., Sherman M.Y. Proteasome inhibitors activate stress kinases and induce Hsp72 Diverse effects on apoptosis . J Biol Chem. 273:1998;6373-6379.
40. 2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem. 272:1997;10110-10116.
41. Yang D.D., Kuan C.-Y., Whitmarsh A.J., Rincón M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389:1997;865-870.
42. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
43. Berra E., Diaz-Meco M.T., Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem. 273:1998;10792-10797.